These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 16900013

  • 21. Mechanisms of target organ damage caused by hypertension: therapeutic potential.
    Cohuet G, Struijker-Boudier H.
    Pharmacol Ther; 2006 Jul; 111(1):81-98. PubMed ID: 16288809
    [Abstract] [Full Text] [Related]

  • 22. Lessons to be learned from 24-hour ambulatory blood pressure monitoring.
    Mancia G, Omboni S, Parati G.
    Kidney Int Suppl; 1996 Jun; 55():S63-8. PubMed ID: 8743513
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
    Ferrari P, Ferrandi M, Valentini G, Manunta P, Bianchi G.
    Med Hypotheses; 2007 Jun; 68(6):1307-14. PubMed ID: 17097240
    [Abstract] [Full Text] [Related]

  • 27. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 28. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E, Kataoka K, Shintaku H, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ichijo H, Ogawa H, Kim-Mitsuyama S.
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [Abstract] [Full Text] [Related]

  • 29. Vascular permeability, blood pressure, and organ damage in primary hypertension.
    Viazzi F, Leoncini G, Ratto E, Parodi A, Falqui V, Conti N, Tomolillo C, Ravera G, Deferrari G, Pontremoli R.
    Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
    [Abstract] [Full Text] [Related]

  • 30. [Impact of antihypertensive treatment on target organs].
    Fregoso Padilla J.
    Arch Cardiol Mex; 2002 May; 72 Suppl 1():S58-63. PubMed ID: 12001872
    [Abstract] [Full Text] [Related]

  • 31. Managing cardiovascular and renal risk: the potential of direct renin inhibition.
    Sever PS, Gradman AH, Azizi M.
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):65-76. PubMed ID: 19502253
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 34. Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.
    Subramaniam V, Lip GY.
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):703-13. PubMed ID: 19505285
    [Abstract] [Full Text] [Related]

  • 35. Effects of anti-hypertensive drugs on vessel rarefaction.
    Battegay EJ, de Miguel LS, Petrimpol M, Humar R.
    Curr Opin Pharmacol; 2007 Apr; 7(2):151-7. PubMed ID: 17276727
    [Abstract] [Full Text] [Related]

  • 36. Recent insights in the development of organ damage caused by hypertension.
    Persu A, De Plaen JF.
    Acta Cardiol; 2004 Aug; 59(4):369-81. PubMed ID: 15368798
    [Abstract] [Full Text] [Related]

  • 37. Synergism of hydrochlorothiazide and nifedipine on blood pressure variability reduction and organ protection in spontaneously hypertensive rats.
    Xie HH, Zhang XF, Chen YY, Shen FM, Su DF.
    Hypertens Res; 2008 Apr; 31(4):685-91. PubMed ID: 18633181
    [Abstract] [Full Text] [Related]

  • 38. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL, Qin XC, Pan ZY, Chen K, Zhang YF, Cui WY, Liu GS, Wang H.
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [Abstract] [Full Text] [Related]

  • 39. [Hypertension and the heart].
    Wachtell K, Andersen NH, Svendsen TL.
    Ugeskr Laeger; 2009 Jun 15; 171(25):2113-6. PubMed ID: 19671394
    [Abstract] [Full Text] [Related]

  • 40. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T, Berthelot A, Bouhaddi M, Laurant P, André C, Guillaume Y, Demougeot C.
    J Hypertens; 2008 Jun 15; 26(6):1110-8. PubMed ID: 18475148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.